The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD population and the adoption of premium devices. However, lack of reimbursement and cost constraints will limit market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the Asia Pacific region across a 10-year period.

Table of contents

  • Peripheral Vascular Devices - Market Insights - Asia Pacific (Supplemental)

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.

Follow Bishwjit on twitter: @Bishwjit_DRG


Related Reports

Peripheral Vascular Devices - Market Insights - Europe Part 2

The European market for PV devices is a dynamic market that will grow through 2029, driven by the availability of new products backed by clinical data. Howe...

View Details

Peripheral Vascular Devices - Market Insights - Japan

The Japanese PV device market will see modest growth through 2029, driven primarily by the expanding ...

View Details

Peripheral Vascular Devices - Market Insights - United States

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for

View Details

Peripheral Vascular Devices - Market Insights - Asia Pacific

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD populatio...

View Details